Evidence map›Paper›PMID 31741002›Full record

ReviewDer Urologe. Ausg. A2019

[The role of the vesical imaging-reporting and data system (VI-RADS) for bladder cancer diagnostics-status quo].

V Hechler, M Rink, D Beyersdorff, M Beer, A J Beer, V Panebianco, M Pecoraro, C Bolenz, G Salomon

Abstract readReview
PubMed Publisher
In one paragraph

Review in Der Urologe. Ausg. A, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

V HechlerKlinik für Urologie und Kinderurologie, Universitätsklinikum Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Deutschland. Veronika.Hechler@uniklinik-ulm.de.
M RinkKlinik und Poliklinik für Urologie, Universitätsklinikum Hamburg Eppendorf, Martinistraße 52, 20246, Hamburg, Deutschland.
D BeyersdorffDiagnostische und Interventionelle Radiologie, Universitätsklinikum Hamburg Eppendorf, Hamburg, Deutschland.
M BeerKlinik für Diagnostische und Interventionelle Radiologie, Universitätsklinikum Ulm, Ulm, Deutschland.
A J BeerKlinik für Nuklearmedizin, Universitätsklinikum Ulm, Ulm, Deutschland.
V PanebiancoDepartment Radiologie, Sapienza Universität Rom, Rom, Italien.
M PecoraroDepartment Radiologie, Sapienza Universität Rom, Rom, Italien.
C BolenzKlinik für Urologie und Kinderurologie, Universitätsklinikum Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Deutschland.
G SalomonKlinik und Poliklinik für Urologie, Universitätsklinikum Hamburg Eppendorf, Martinistraße 52, 20246, Hamburg, Deutschland. gsalomon@uke.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Initial clinical and pathological diagnostic workup of urinary bladder cancer is based on cystoscopy, transurethral resection of suspicious lesions, and computed tomography when indicated. Accurate staging is necessary for further therapeutic decision-making. This review summarizes the current status of multiparametric magnetic resonance imaging (mpMRI) and the vesical imaging-reporting and data system (VI-RADS) classification. MpMRI may improve the accuracy of assessment of local tumor invasion compared to conventional imaging alone. VI-RADS standardizes reporting of MRI staging and classifies the likelihood of muscle-invasive bladder cancer into five categories. Preliminary data suggest low interobserver variability. However, prospective multicenter studies are necessary to validate the VI-RADS classification. Progress in functional, molecular, and hybrid imaging may further improve the accuracy of clinical tumor and nodal staging for bladder cancer.

Indexed as

Data SystemsUrinary Bladder NeoplasmsHumansMagnetic Resonance ImagingMaleNeoplasm InvasivenessProspective StudiesMagnetic resonance imaging, multiparametricMultimodal therapyNeoadjuvant therapyStagingUrothelial carcinoma

Identifiers

PMID31741002

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.